Medico Remedies

52
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
42.85
-0.01 (-0.02%)
BSENSE

Jun 19, 01:31 PM

BSE+NSE Vol: 24.73 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024

Compare Profit and Loss Results of Medico Remedies
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
2.00
148.00
7,400.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
2.00
148.00
7,400.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
0.00
-5.00
0%
Raw Materials Consumed
113.00
2.00
111.00
5,550.00%
Power & Fuel Cost
2.00
0.00
2.00
0%
Employee Cost
6.00
0.00
6.00
0%
Operating Expenses
7.00
0.00
7.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
0.00
6.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
135.00
4.00
131.00
3,275.00%
Operating Profit (PBDIT) excl Other Income
15.00
-1.00
16.00
1,600.00%
Other Income
2.00
8.00
-6.00
-75.00%
Operating Profit (PBDIT)
17.00
7.00
10.00
142.86%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
16.00
7.00
9.00
128.57%
Depreciation
3.00
0.00
3.00
0%
Profit Before Taxation & Exceptional Items
13.00
7.00
6.00
85.71%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
7.00
6.00
85.71%
Provision for Tax
3.00
1.00
2.00
200.00%
Profit After Tax
10.00
5.00
5.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
32.00
42.00
-10.00
-23.81%
Profit Available for appropriations
42.00
47.00
-5.00
-10.64%
Appropriations
42.00
47.00
-5.00
-10.64%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.22
4.27
-3.05
-71.43%
Profit And Loss - Net Sales
Net Sales 150.94 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024

Profit And Loss - Interest
Interest 1.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.09 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024